Combined modality treatment with chemotherapy and radiation in locally advanced non-small cell lung cancer

Lung Cancer

Volumn 34, Issue SUPPL. 2, 2001, Pages

  Jassem, Jacek ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Chemotherapy; Combined modality treatment; NSCLC; Radiotherapy

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; GEMCITABINE; LOMUSTINE; NAVELBINE; PACLITAXEL; PLATINUM DERIVATIVE; VINBLASTINE; VINDESINE;

ADVANCED CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; CONFERENCE PAPER; HUMAN; LUNG NON SMALL CELL CANCER; METHODOLOGY; MULTIMODALITY CANCER THERAPY; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; PROBABILITY; TREATMENT OUTCOME;

EID: 0035197144     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-5002(01)00366-X     Document Type: Conference Paper

References (23)

1. Lung cancer
2. Improved survival in stage III non-small-cell lung cancer: Seven-year follow-up of cancer and leukemia group B [CALGB] 8433 trial
3. Final results of phase III trial in regionally advanced unresectable non-small cell lung cancer
4. Significant effect of adjuvant chemotherapy on survival in locally advanced non-small-cell lung carcinoma
5. Inoperable non-small cell lung cancer: Radiation with or without chemotherapy
6. Thoracic radiation therapy alone compared with chemoradiotherapy for locally unresectable non-small cell carcinoma of the lung
7. Mitomycin, ifosfamide and cisplatin in unresectable non-small-cell lung cancer: Effects on survival and quality of life
8. Comparison of induction chemotherapy before radiotherapy with radiotherapy only in patients with locally advanced squamous cell carcinoma of the lung
9. Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomised clinical trials
10. Effects of concomitant cisplatin and radiotherapy on inoperable non-small cell lung cancer
11. Radiotherapy versus radiotherapy enhanced by cisplatin in stage III non-small cell lung cancer
12. A phase III trial of thoracic irradiation with and without concomitant cisplatin for locally advanced unresectable non-small cell lung cancer: A Hoosier Oncology Group study
13. The possible advantage of hyperfractionated thoracic radiotherapy in the treatment of locally advanced nonsmall cell lung carcinom
14. A randomized phase III study of accelerated or standard fraction radiotherapy with or without concurrent carboplatin in inoperable non-small cell lung cancer: Final report of an Australian multi-centre trial
15. Radiosensitization with carboplatin for patients with unresectable stage III non-small cell lung cancer: A phase III trial of the Cancer and Leukemia Group B and the Eastern Cooperative Oncology Group
16. Randomized trial of hyperfractionated radiation therapy with or without concurrent chemotherapy for stage III non-small-cell lung cancer
17. Hyperfractionated radiation therapy with or without concurrent low-dose daily carboplatin/etoposide for stage III non-small-cell lung cancer: A randomized study
18. Phase III study of concurrent vs. sequential thoracic radiotherapy in combination with mitomycin, vindesine and cisplatin in unresectable stage III non-small cell lung cancer: Five-year median follow-up results
19. A quality-adjusted time without symptoms or toxicity (QTWiST)
20. Combined chemotherapy and radiation in locally advanced non-small cell lung cancer
21. Chemotherapy of advanced non-small cell lung cancer
22. CALGB Study 9431: A randomized phase II study of cisplatin with gemcitabine or paclitaxel or vinorelbine as induction chemotherapy (Ind CT) and concomitant chemoradiotherapy (XRT) for unresectable stage III non-small cell lung cancer (NSCLC)
23. Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: A randomised multicentre trial